The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ODENZA: A French prospective, randomized, open-label, multicenter, cross-over phase II trial of preference between darolutamide and enzalutamide in men with asymptomatic or mildly symptomatic metastatic castrate-resistant prostate cancer (CRPC).
 
Emeline Colomba
Honoraria - BMS Brazil; GlaxoSmithKline; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Clovis Oncology; GlaxoSmithKline; Ipsen; Merck; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Sarah Flora Jonas
No Relationships to Disclose
 
Jean-Christophe Eymard
Honoraria - Sandoz-Novartis
 
Remy Delva
No Relationships to Disclose
 
Pierre-Emmanuel Brachet
No Relationships to Disclose
 
Yann Neuzillet
Honoraria - Astellas Amgen BioPharama; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Merck Sharp & Dohme
Consulting or Advisory Role - Bouchara Recordati; Janssen-Cilag; Sanofi
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Guilhem Roubaud
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Hakim Mahammedi
Honoraria - AstraZeneca; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Janssen Oncology; Pfizer; Sanofi; Sanofi/Aventis
Travel, Accommodations, Expenses - Astellas Medivation; Astellas Pharma; Bayer; Janssen; MSD Oncology; Roche; Sanofi
 
Raffaele Longo
No Relationships to Disclose
 
Carole Helissey
Honoraria - AstraZeneca; Janssen; Roche; Sanofi
Consulting or Advisory Role - Astellas Amgen BioPharama; Janssen; Roche; Sanofi
 
Philippe Barthelemy
Honoraria - Astellas Pharma; EUSA Pharma
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Roche
 
Delphine Borchiellini
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer; Roche
 
Ali Hasbini
No Relationships to Disclose
 
Franck Priou
No Relationships to Disclose
 
Carolina Saldana
Honoraria - Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Pfizer; Sanofi
 
Eric Voog
No Relationships to Disclose
 
Stéphanie Foulon
No Relationships to Disclose
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer; Janssen (Inst); Sanofi (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bristol-Myers Squibb; Clovis Oncology; Curevac; ESSA (Inst); Janssen Oncology (Inst); Orion; Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen; MSD